Ethylene thiourea (2 mercaptoimidazoline) has been used as an accelerator in the rubber industry since 1948. It is also used as a chemical intermediate in the production of bactericides, pesticides and fungicides, dyestuffs, and photographic chemicals and was used at one time as a drug for treating thyrotoxicosis.
No hazard to health from this material was recorded until 1969 when liver tumours were reported in mice after the oral administration of 215 mg/kg.' In 1972 the induction of thyroid carcinoma in rats and hypoplastic and simple goitre was reported after the oral administration of 350 ppm. 2 The International Agency for Research in Cancer of the World Health Organisation3 has evaluated the carcinogenic risk of ethylene thiourea (ETU) to man and classified it as an antithyroid substance and as a suspect carcinogen, since this type of substance is believed to induce thyroid tumours through the suppression of thyroxin synthesis leading to hyperplasia of the thyroid gland.
In 1973 the Industrial Health Advisory Committee of the Department of Employment reported on ETU reviewing the evidence collected at that time (private communication). It concluded that unless there is clinical evidence of thyroid disease in exposed populations, it was unlikely that ETU would prove to be a thyroid carcinogen and suggested that the possibility of screening for thyroid stimulating hormone (TSH) on small, but highly exposed, industrial populations might be explored on a research basis. At the time this was thought impractical in the United Kingdom since the small population at the one manufacturing plant was not thought to be highly exposed.
Two studies were carried out in the United States, however, by Gordon et ETU is produced by reacting ethylene diamine with carbon disulphide (CS2) in a closed reactor. This is followed by various processes to produce a dust suppressed powder that is bagged off under local exhaust ventilation. Some operations are very dusty, and the operatives exposed to high levels were wearing respirators; the greatest exposure was considered to occur in the bagging process. Until 1977 not all employees used respiratory protection or gloves, and the ventilation was not satisfactory at the weighing operation. This has now been rectified and exposures are thought to be lower than that measured in 1976 by the field consultant group of the Health and Safety Executive. Samples of background atmosphere were taken in various parts of the plant, and some personal samples were also taken. Levels up to 330 ugem3 were found on one personal sampler; the background levels were in the range 10 ,ug/m3-240 ,g/m3. The operation is now noticeably less dusty but monitoring has not been repeated.
The jobs of the production workers are largely interchangeable so that differences in individual exposure are likely to be insignificant. The average length of exposure of these workers is 10 years with a range of five to 20 years. FACTORY 2 At factory 2 the powder is mixed into ethylene propylene diene monomer (EPDM) rubber, and the mixture rolled into sheets. Originally the powder was supplied in paper sacks that were slit open and tipped into a Banbury mixer. This was a dusty process and in 1980 levels of 120-160 ,ug/m3 were recorded on personal samplers. From 23 February to 9 March 1981, the packaging was changed to a low melt plastic bag which was put into the mixer pierced but unopened. Loose powder was again used from 16 to 20 March 1981. Since 4 May 1981 all the ETU has been in low melt plastic bags. A total of 46 tonnes of ETU was processed in 1981. In these operations the mixers are exposed to more ETU dust than the process workers. Four of the mixers experienced more exposure than the fifth, who is employed partly in a supervisory capacity. All five mixers have been exposed since 1977 when the process started.
A control population was obtained from other production workers and from managerial staff. USERS ETU was originally supplied to rubber manufacturers as a powder and later as a dust suppressed powder. Since 1978 all ETU from this factory has been supplied in the encapsulated form. The original reason for the encapsulation of many rubber chemicals was to promote the efficacy of the mixing process,'0 but in the case of ETU and other compounds the main consideration is the health hazard. The NIOSH Health Hazard Evaluation8 found that when encapsulated ETU was substituted for the powdered form in manufacturing operations, occupational exposure is much less likely to occur, and its major recommendation was for encapsulation.
The main avenue of absorption is thought to be inhalation but since ETU is fat soluble, it could also be absorbed through intact skin. This is likely to be a less important route than inhalation, however, since protective clothing and gloves are worn.
Methods
All the exposed workers at both factories agreed to take part in the survey. They were all male with an age range of 26 to 62 at factory 1 and 28 to 56 at factory 2.
Control populations were obtained from volunteer male workers on processes not involving ETU or related to compounds at factory 1, and from other male shop floor workers and management at factory 2. As some contamination of factory 2 with ETU powder was suspected originally, male controls from two metal working factories in the same area were also obtained. Table 2 shows these parameters and the resulting p values (two-tailed). These data confirm the impression that the results from the mixers are clearly lower than those from the control group. The difference between the controls and the process workers is slight, and is due entirely to one individual with particularly low levels. The difference between the mixers and the process workers lies on the borderline of statistical significance.
The TSH results in the exposed process workers, mixers, and controls were not treated statistically because the increase that occurs in hypothyroidism is so large that mean levels would be uninformative. The TSH levels were within normal limits in all the controls and process workers (range 2*1-5*4 nmol/ 1). In one mixer the levels on two occasions were unacceptably high (21-8 nmol/I and 17-0 nmol/l) and he was investigated further and found to have premyxoedema.
The TBG levels and the TJTBG ratios did not differ among the groups and were within normal limits.
Discussion
There is no evidence that thyroid function is severely affected by exposure to ETU at the levels experienced by these workers, nor was there any clinical evidence of any effect. Only one worker was considered to be hypothyroid on biological testing. The T4 results in the exposed workers were generally, however, lower than those in the control subjects. Most of this difference in distribution was accounted for by the results from the mixers, results from the process workers being fairly evenly spread The mean T4 results for all five mixers were below the laboratory mean of 100 nmol/l; indeed only one result of the 22 in this group was above 100. The levels in the process workers were more evenly spread, with five individuals below and five above 100 nmolIl. In the control group 13 individuals had levels below 100 and 21 above (see fig) .
ETU resembles thiouracil in its effects, which are likely to be on the iodination of tyrosine after iodide has been oxidised to iodine. The resulting low levels of thyroxine would lead to stimulation of TSH production, and thyroid hypertrophy. The results seen in one mixer, low levels of thyroxine and high levels of TSH, are those that might be expected to result from a goitrogen. The generally low level of thyroxine would appear to bear out the contention that ETU was being absorbed by some workers.
There is at present no threshold limit value or control limit for ETU. The NIOSH Hazard Review8 suggested precautions in manufacturing and use, many of which are already being carried out in the United Kingdom. These include the exclusion of women of childbearing potential from exposure, prohibition of eating and smoking in the workplace, general hygiene, the encapsulation of the powder into masterbatch rubber, and local exhaust ventilation.
Personal respiratory protection should be worn when exposure to a dust or vapour hazard is likely, and NIOSH gives a level of 30 ppm for this. NIOSH 140 150 160 170 estimated that in the United States about 17 000 employees in 24 different occupations were potentially exposed to ETU in their working environment, but some of the categories quotes must have minimal exposure-for example, only five of the 54 workers tested in their survey had significant exposure, and of these, only one handled ETU powder. If the material is encapsulated most of the other categories would disappear.
The mixing operation in the United Kingdom leads to greater exposure than the process work; this was predicted when it was started and unfortunately proved in practice to be the case, despite precautions. Attention should be paid to reducing exposure by improving housekeeping, by the use of local exhaust ventilation, and, when necessary, by personal respiratory protection. 
